C. Scrase

发表

Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial.

M. Parmar, M. Sydes, D. Dearnaley, 2007, The Lancet. Oncology.

Consensus Guidelines and Contouring Atlas for Pelvic Node Delineation in Prostate and Pelvic Node Intensity Modulated Radiation Therapy.

John Staffurth, Emma Hall, Helen McNair, 2015, International journal of radiation oncology, biology, physics.

Guidelines for primary radiotherapy of patients with prostate cancer.

Michel Bolla, Raymond Miralbell, Alberto Bossi, 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Guidelines for target volume definition in post-operative radiotherapy for prostate cancer, on behalf of the EORTC Radiation Oncology Group.

Michel Bolla, Raymond Miralbell, Zvi Symon, 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial

Emma Hall, Kevin J Harrington, S. Bhide, 2011, The Lancet. Oncology.

Interobserver variation in clinical target volume and organs at risk segmentation in post-parotidectomy radiotherapy: can segmentation protocols help?

G A Whitfield, R Jena, T. Roques, 2012, The British journal of radiology.

Bone density in men receiving androgen deprivation therapy for prostate cancer: A randomized comparison between transdermal estrogen and luteinising hormone-releasing hormone agonists.

M. Parmar, P. Abel, H. Kynaston, 2014 .

Quality assurance for the EORTC 22071–26071 study: dummy run prospective analysis

M. Tomsej, Sunita Ghosh, A. Fairchild, 2014, Radiation oncology.

Review article Practical experience with intensity-modulated radiotherapy

A. Poynter, C. Scrase, H. James, 2004 .

Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array

J. R. Wilson, David M. Holden, P. W. Foster, 2016, British Journal of Cancer.

Intensity modulated radiotherapy (IMRT) in the management of locally advanced oropharyngeal squamous cell carcinomata (SCC): disease control and functional outcome using the therapy outcome measure (TOM) score - report from a single U.K. institution

C. Scrase, K. Yip, C. Ingle, 2010, Head & neck oncology.

Clinical and patient‐reported outcomes of SPARE – a randomised feasibility study of selective bladder preservation versus radical cystectomy

J. Donovan, R. Huddart, D. McLaren, 2017, BJU international.

Nonrandomized Comparison of Efficacy and Side Effects of Bicalutamide Compared With Luteinizing Hormone-Releasing Hormone (LHRH) Analogs in Combination With Radiation Therapy in the CHHiP Trial

D. Dearnaley, V. Khoo, J. Staffurth, 2022, International journal of radiation oncology, biology, physics.

The Efficacy and Safety of Conventional and Hypofractionated High-Dose Radiation Therapy for Prostate Cancer in an Elderly Population: A Subgroup Analysis of the CHHiP Trial.

D. Dearnaley, V. Khoo, C. Parker, 2018, International journal of radiation oncology, biology, physics.

Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial

P. Dziewulski, M. Gore, M. Highley, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

A Randomised Comparison Evaluating Changes in Bone Mineral Density in Advanced Prostate Cancer: Luteinising Hormone-releasing Hormone Agonists Versus Transdermal Oestradiol

M. Parmar, P. Abel, H. Kynaston, 2016, European urology.

Comparison of hypofractionated high-dose intensity-modulated radiotherapy schedules for prostate cancer: Results from the phase III randomized CHHiP trial (CRUK/06/016).

D. Dearnaley, V. Khoo, J. Logue, 2016 .

Dose-escalated intensity-modulated radiotherapy in patients with locally advanced laryngeal and hypopharyngeal cancers: ART DECO, a phase III randomised controlled trial.

S. Bhide, K. Harrington, T. Roques, 2021, European journal of cancer.

Impact of Prostate Cancer Hypofractionation on Patient Reported Outcomes: Baseline to 5 Years Change in the CHHIP Trial

D. Dearnaley, V. Khoo, C. Parker, 2018, International Journal of Radiation Oncology*Biology*Physics.

Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial

Annie Gao, Clare Griffin, John Staffurth, 2016, The Lancet. Oncology.

Squamous Cell Carcinoma of the Temporal Bone: Clinical Outcomes From Radical Surgery and Postoperative Radiotherapy

T. Roques, A. Durrani, J. Tysome, 2014, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

First results of a phase III multicenter randomized controlled trial of intensity modulated (IMRT) versus conventional radiotherapy (RT) in head and neck cancer (PARSPORT: ISRCTN48243537).

K. Harrington, R. A’Hern, C. Nutting, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Evaluation of erectile potency and radiation dose to the penile bulb using image guided radiotherapy in the CHHiP trial

D. Dearnaley, V. Khoo, C. Parker, 2019, Clinical and translational radiation oncology.

COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study

D. Kerr, T. Powles, Y. Drew, 2020, The Lancet Oncology.

The early toxicity of escalated versus standard dose conformal radiotherapy with neo-adjuvant androgen suppression for patients with localised prostate cancer: results from the MRC RT01 trial (ISRCTN47772397).

M. Sydes, D. Dearnaley, R. Huddart, 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 CHHiP trial

Annie Gao, Clare Griffin, John Staffurth, 2015, The Lancet. Oncology.

Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial.

M. Parmar, M. Sydes, D. Dearnaley, 2014, The Lancet. Oncology.

Short Androgen Suppression and Radiation Dose Escalation for Intermediate- and High-Risk Localized Prostate Cancer: Results of EORTC Trial 22991.

L. Collette, M. Bolla, J. Bosset, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trial.

Annie Gao, John Staffurth, Peter Kirkbride, 2012, The Lancet. Oncology.

Transdermal oestradiol for androgen suppression in prostate cancer: long-term cardiovascular outcomes from the randomised Prostate Adenocarcinoma Transcutaneous Hormone (PATCH) trial programme

M. Parmar, M. Nankivell, N. Clarke, 2021, The Lancet.

Short Androgen Suppression and Radiation Dose Escalation in Prostate Cancer: 12-Year Results of EORTC Trial 22991 in Patients With Localized Intermediate-Risk Disease

L. Collette, P. Maingon, M. Bolla, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of Hypofractionated Radiotherapy on Patient-reported Outcomes in Prostate Cancer: Results up to 5 yr in the CHHiP trial (CRUK/06/016)

D. Dearnaley, V. Khoo, C. Parker, 2021, European urology oncology.

Two-years Postradiotherapy Biopsies: Lessons from MRC RT01 Trial

M. Sydes, D. Dearnaley, D. Nicol, 2018, European urology.

Toxicity and Patient-Reported Outcomes of a Phase 2 Randomized Trial of Prostate and Pelvic Lymph Node Versus Prostate only Radiotherapy in Advanced Localised Prostate Cancer (PIVOTAL)

D. Dearnaley, V. Khoo, J. Staffurth, 2019, International journal of radiation oncology, biology, physics.

Practical experience with intensity-modulated radiotherapy.

A. Poynter, C. Scrase, H. James, 2004, The British journal of radiology.

Prostate Cancer Two-years Postradiotherapy Biopsies : Lessons from MRC RT 01 Trial

M. Sydes, D. Dearnaley, D. Nicol, 2018 .

A randomised assessment of image guided radiotherapy within a phase 3 trial of conventional or hypofractionated high dose intensity modulated radiotherapy for prostate cancer

D. Dearnaley, V. Khoo, C. Parker, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Forward- and Inverse-Planned Intensity-Modulated Radiotherapy in the CHHiP Trial: A Comparison of Dosimetry and Normal Tissue Toxicity

D. Dearnaley, V. Khoo, S. Hassan, 2019, Clinical oncology (Royal College of Radiologists (Great Britain)).

Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial.

S. Bhide, K. Harrington, C. Clark, 2011, The Lancet. Oncology.

8LBA 5 year outcomes of a phase III randomised trial of conventional or hypofractionated high dose intensity modulated radiotherapy for prostate cancer (CRUK/06/016): report from the CHHiP Trial Investigators Group

D. Dearnaley, V. Khoo, J. Logue, 2015 .

Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial

S. Bhide, K. Harrington, C. Clark, 2011, The Lancet. Oncology.

Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial

D. Dearnaley, V. Khoo, C. Parker, 2016, The Lancet. Oncology.

Title : A randomised assessment of image guided radiotherapy within a phase 3 trial of Conventional or Hypofractionated High Dose Intensity Modulated Radiotherapy for Prostate Cancer ( CHHiP )

Parker, D. Dearnaley, V. Khoo, 2018 .

First results of a phase III multicenter randomized controlled trial of intensity modulated (IMRT) versus conventional radiotherapy (RT) in head and neck cancer (PARSPORT: ISRCTN48243537; CRUK/03/005).

K. Harrington, R. A’Hern, C. Nutting, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.